The present study indicated that patients with STEMI who had elevated NT-proBNP levels and an ECG with a Tpeak-end/QT interval ratio larger than 0.3 were at more risk of major adverse cardiac events, such as heart failure. The gene discussed is NPPB; the disease is heart failure.